Viking Therapeutics VKTX
NASDAQ VKTX
$24.40 -1.43 (-5.54%)
At close: Oct 23, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Gains from Investment Securities (2024 - 2026)

Updated

Analysis

Viking Therapeutics (VKTX) Gains from Investment Securities (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Viking Therapeutics 2.85 Bn 328.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30,000.00
Dec 31, 2025 41,000.00
Sep 30, 2025 10,000.00
Dec 31, 2024 1,000.00
Sep 30, 2024 113,000.00
Jun 30, 2024 2,000.00
API Access

Viking Therapeutics Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=VKTX&period=max&api_key=YOUR_API_KEY